Evidence map›Paper›PMID 33173728›Full record

ReviewAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2020

The Coppery Age: Copper (Cu)-Involved Nanotheranostics.

Caihong Dong, Wei Feng, Wenwen Xu, Luodan Yu, Huiijng Xiang, Yu Chen, Jianqiao Zhou

Open access · goldAbstract readReview
In one paragraph

Review in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
8.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 223 citations in OpenAlex.

  1. Article
  2. Recyclable Green Synthesis of CuAngewandte Chemie (International ed. in English) · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Recent Trends in Biomedical Applications of CuInternational journal of nanomedicine · 2025
    Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Caihong DongDepartment of Ultrasound Zhongshan Hospital Fudan University Shanghai 200032 P. R. China.
Wei FengSchool of Life Sciences Shanghai University Shanghai 200444 P. R. China.
Wenwen XuDepartment of Ultrasound Ruijin Hospital Shanghai Jiaotong University School of Medicine Shanghai 200025 P. R. China.
Luodan YuSchool of Life Sciences Shanghai University Shanghai 200444 P. R. China.
Huiijng XiangState Key Laboratory of High Performance Ceramics and Superfine Microstructure Shanghai Institute of Ceramics Chinese Academy of Sciences Shanghai 200050 P. R. China.
Yu ChenSchool of Life Sciences Shanghai University Shanghai 200444 P. R. China.ORCID https://orcid.org/0000-0002-8206-3325
Jianqiao ZhouDepartment of Ultrasound Ruijin Hospital Shanghai Jiaotong University School of Medicine Shanghai 200025 P. R. China.
Shanghai University · CNRuijin Hospital · CNChinese Academy of Sciences · CNSun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As an essential trace element in the human body, transitional metal copper (Cu) ions are the bioactive components within the body featuring dedicated biological effects such as promoting angiogenesis and influencing lipid/glucose metabolism. The recent substantial advances of nanotechnology and nanomedicine promote the emerging of distinctive Cu-involved biomaterial nanoplatforms with intriguing theranostic performances in biomedicine, which are originated from the biological effects of Cu species and the physiochemical attributes of Cu-composed nanoparticles. Based on the very-recent significant progresses of Cu-involved nanotheranostics, this work highlights and discusses the principles, progresses, and prospects on the elaborate design and rational construction of Cu-composed functional nanoplatforms for a diverse array of biomedical applications, including photonic nanomedicine, catalytic nanotherapeutics, antibacteria, accelerated tissue regeneration, and bioimaging. The engineering of Cu-based nanocomposites for synergistic nanotherapeutics is also exemplified, followed by revealing their intrinsic biological effects and biosafety for revolutionizing their clinical translation. Finally, the underlying critical concerns, unresolved hurdles, and future prospects on their clinical uses are analyzed and an outlook is provided. By entering the "Copper Age," these Cu-involved nanotherapeutic modalities are expected to find more broad biomedical applications in preclinical and clinical phases, despite the current research and developments still being in infancy.

Indexed as

antibacteriabioimagingcancer therapycopper nanoparticlesnanomedicinetissue regeneration

Identifiers

PMID33173728
PMCPMC7610332
OpenAlexW3049411042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.